SEC Company Response from SRX Global (SRXH) — Dec 10, 2025
SRX Global Inc.
Date: Dec. 10, 2025 · CIK: 0001471727 · Accession: 0001493152-25-027100
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291262
Letter
SRx Health Solutions, Inc.
801 US Highway 1
North Palm Beach, FL
December 10, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street, N.E.
Washington, DC 20549
Attention: Randy Acker
Re: SRx Health Solutions, Inc.
Registration Statement on Form S-1
Filed on November 4, 2025
File No. 333-291262
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, SRx Health Solutions, Inc., a Delaware corporation (the "Registrant"), hereby requests acceleration of the effective date of the above-referenced Registration Statement such that it may become effective on Monday, December 15, 2025 at 3:00 p.m. Eastern Time or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(i) should the Securities and Exchange Commission (the "Commission") or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii) the Registrant may not assert the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Meister Seelig & Fein PLLC, by calling Louis Lombardo at (212) 655-3518.
Thank you for your assistance in this matter.
Very truly yours,
SRx HEALTH SOLUTIONS, Inc.
Show Raw Text
CORRESP 1 filename1.htm SRx Health Solutions, Inc. 801 US Highway 1 North Palm Beach, FL 33408 December 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, DC 20549 Attention: Randy Acker Re: SRx Health Solutions, Inc. Registration Statement on Form S-1 Filed on November 4, 2025 File No. 333-291262 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, SRx Health Solutions, Inc., a Delaware corporation (the "Registrant"), hereby requests acceleration of the effective date of the above-referenced Registration Statement such that it may become effective on Monday, December 15, 2025 at 3:00 p.m. Eastern Time or as soon thereafter as practicable. The Registrant hereby acknowledges that: (i) should the Securities and Exchange Commission (the "Commission") or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and (iii) the Registrant may not assert the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Meister Seelig & Fein PLLC, by calling Louis Lombardo at (212) 655-3518. Thank you for your assistance in this matter. Very truly yours, SRx HEALTH SOLUTIONS, Inc. By: /s/ Carolina Martinez Name: Carolina Martinez Title: Chief Financial Officer cc: Louis Lombardo, Esq., Meister Seelig & Fein LLP